“Three Year Anniversary of the Introduction of Deucravacitinib to the US Market”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 5, Sept. 2025, pp. 2705-8, https://doi.org/10.25251/mad6yd50.